Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Queensland Health
Mallinckrodt
Healthtrust
Boehringer Ingelheim
Covington
Citi
McKesson
Daiichi Sankyo

Generated: October 23, 2017

DrugPatentWatch Database Preview

SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH Drug Profile

« Back to Dashboard

Which patents cover Sulfamethoxazole And Trimethoprim Single Strength, and what generic Sulfamethoxazole And Trimethoprim Single Strength alternatives are available?

Sulfamethoxazole And Trimethoprim Single Strength is a drug marketed by Teva Pharms and is included in one NDA.

The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH is sulfamethoxazole; trimethoprim. There are twenty-six drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.

Summary for Tradename: SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list5
Clinical Trials: see list108,376
Patent Applications: see list96
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH
sulfamethoxazole; trimethoprim
TABLET;ORAL070030-001Jun 2, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
Cipla
McKinsey
Mallinckrodt
Moodys
Healthtrust
US Department of Justice
QuintilesIMS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot